.png&w=3840&q=75)
apryl (acq. by Progyny) has secured $4.5 million in new investment capital from investors, marking a significant milestone for the fertility benefits platform. This funding round will support the company's mission to empower individuals on their family planning journeys.
Operating as Progyny Global, the company provides a comprehensive fertility benefits platform designed to help employers attract and retain top talent while advancing diversity and inclusion initiatives. Progyny Global enables companies to offer their employees robust support for fertility and family planning, encompassing consultations, access to specialized clinics, and various treatments such as egg freezing or in vitro fertilization (IVF), as well as adoption support. These benefits are subsidized by the employer, ensuring confidentiality and accessibility for employees. The platform also focuses on educating employees, providing them with the knowledge to understand their options and make proactive decisions about their reproductive health.
The $4.5 million investment is intended to accelerate Progyny Global's growth initiatives and enhance its platform capabilities. This capital infusion will enable the company to expand its reach, serving more employers and their workforces with essential family planning resources. Progyny Global is built on the principle that everyone deserves the same opportunities to become a parent, irrespective of age, gender, sexual orientation, relationship status, or financial standing.
With this funding, Progyny Global is well-positioned to strengthen its role as a vital partner for organizations committed to offering inclusive and comprehensive employee benefits. The company aims to continue expanding its services, reinforcing its dedication to supporting diverse paths to parenthood and fostering a more equitable workplace environment.
